Yungjin Pharm. Co., Ltd. (CEO Byung Hwan Ryoo) signed a Supply Agreement of Cefcapene granule, the 3^rd Cephalosporin, with Zhongshan Belling Technology Co., Ltd. (China) on 6^th of March.

Upon the completion of drug registration from China Food and Drug Administration, Yungjin Pharm. Co., Ltd. will start exporting Cefcapene granule to China. Yungjin pharm. Co., Ltd. has signed a Supply Agreement of Multi-Vitamin syrup with Qingdao Baheal Medical Science & Technology previously. Yungjin Pharm. Co., Ltd. is actively expanding its business area to Chinese finished product market.

Once the Yungjin Pharm. Co., Ltd.’s products are registered and exported actively to China, Yungjin Pharm. Co., Ltd. is expected to have global competitive power in China as well as existing Japan market. Yungjin Pharm. Co., Ltd. was awarded with the ’50 Million Export Tower award’ in 2013 after the company was awarded with the ’20 Million Export Tower award’ in 2010.